1.76
-0.02(-1.12%)
Currency In USD
| Previous Close | 1.78 |
| Open | 1.74 |
| Day High | 1.79 |
| Day Low | 1.63 |
| 52-Week High | 2.66 |
| 52-Week Low | 0.85 |
| Volume | 8.3M |
| Average Volume | 8.24M |
| Market Cap | 528.65M |
| PE | -0.83 |
| EPS | -2.13 |
| Moving Average 50 Days | 1.55 |
| Moving Average 200 Days | 1.37 |
| Change | -0.02 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $228.27 as of November 08, 2025 at a share price of $1.76. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $118.52 as of November 08, 2025 at a share price of $1.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HiFi Solves Consortium Publishes First Major Study Demonstrating the Clinical Research Power of PacBio HiFi Genomes
GlobeNewswire Inc.
Nov 05, 2025 2:05 PM GMT
New multi-center study identifies 100% of clinically relevant variants in the study, including those not detected by short-read sequencing technologies, positioning HiFi as the bridge between research and clinical-grade genomicsMENLO PARK, Calif., No
PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China
GlobeNewswire Inc.
Nov 04, 2025 2:05 PM GMT
NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemiaMENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), d
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
GlobeNewswire Inc.
Oct 22, 2025 8:05 PM GMT
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 pm Eastern Time.